Bank of Montreal
TXG icon

Bank of Montreal’s 10x Genomics TXG Stock Holding History

Bank of Montreal’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
29,156
+2,854
+11% +$74.8K ﹤0.01% 2033
2026
Q1 		$558K Sell
26,302
-4,415
-14% -$88.3K ﹤0.01% 2340
2025
Q4 		$501K Sell
30,717
-557,894
-95% -$8.43M ﹤0.01% 2311
2025
Q3 		$6.88M Buy
588,611
+531
+0.1% +$6.92K ﹤0.01% 1185
2025
Q2 		$6.81M Buy
588,080
+576,047
+4,787% +$5.25M ﹤0.01% 1136
2025
Q1 		$105K Buy
+12,033
New +$152K ﹤0.01% 2908
2024
Q4 		– Sell
-14,576
Closed -$330K – 3943
2024
Q3 		$330K Buy
+14,576
New +$301K ﹤0.01% 2706
2024
Q2 		– Sell
-5,628
Closed -$262K – 4256
2024
Q1 		$262K Sell
5,628
-399,717
-99% -$17.6M ﹤0.01% 2870
2023
Q4 		$23.4M Buy
405,345
+398,760
+6,056% +$17.4M 0.01% 734
2023
Q3 		$328K Sell
6,585
-214,666
-97% -$11.2M ﹤0.01% 2742
2023
Q2 		$12.9M Buy
221,251
+214,425
+3,141% +$11.6M ﹤0.01% 917
2023
Q1 		$382K Sell
6,826
-15,097
-69% -$705K ﹤0.01% 2620
2022
Q4 		$802K Sell
21,923
-470
-2% -$15.4K ﹤0.01% 2324
2022
Q3 		$804K Buy
22,393
+17,470
+355% +$666K ﹤0.01% 2308
2022
Q2 		$242K Buy
4,923
+1,033
+27% +$53.6K ﹤0.01% 3153
2022
Q1 		$293K Sell
3,890
-29,747
-88% -$2.6M ﹤0.01% 3209
2021
Q4 		$5.08M Sell
33,637
-5,796
-15% -$888K ﹤0.01% 1217
2021
Q3 		$5.78M Buy
39,433
+1,594
+4% +$274K ﹤0.01% 1562
2021
Q2 		$7.63M Buy
37,839
+889
+2% +$161K ﹤0.01% 1399
2021
Q1 		$7.03M Buy
36,950
+35,960
+3,632% +$6.21M ﹤0.01% 1188
2020
Q4 		$166K Sell
990
-9,195
-90% -$1.33M ﹤0.01% 3330
2020
Q3 		$1.39M Buy
10,185
+10,123
+16,327% +$1.06M ﹤0.01% 1820
2020
Q2 		$6K Buy
62
+22
+55% +$1.71K ﹤0.01% 4387
2020
Q1 		$2K Hold
40
– – ﹤0.01% 3889
2019
Q4 		$3K Buy
+40
New +$2.4K ﹤0.01% 4757

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Montreal's TXG Position: Q2 2026 in Review

Bank of Montreal increased its 10x Genomics (TXG) stake by 11% in Q2 2026, buying an estimated $74.8K and bringing the position to 29,156 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2033.

Bank of Montreal first reported a position in TXG in Q4 2019 and has held it in 25 quarters since. The position peaked at $23.4M in Q4 2023. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Bank of Montreal held 29,156 shares of 10x Genomics worth $1.12M as of Q2 2026.
  • Bank of Montreal bought 2,854 10x Genomics shares in Q2 2026, an estimated $74.8K.
  • 10x Genomics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2033 holding.
  • Bank of Montreal first reported a position in 10x Genomics in Q4 2019 and has held it in 25 quarters since.
  • Bank of Montreal's 10x Genomics position peaked at $23.4M in Q4 2023.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.